Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled "Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars".
Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled "Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars".